This included two leukemia cell lines, RCH-ACV and REH, known to carry the TCF3:PBX1 and ETV6:RUNX1 fusion genes, respectively, and four prostate cancer samples positive for the TMPRSS2:ERG fusion gene. This evidence concerns the gene TCF3 and prostate carcinoma.